WAYNE, Pa.--(BUSINESS WIRE)--Feb. 10, 2006--PharmaStem Therapeutics, Inc. today announced that it has entered into an agreement under which Lifebank Corp, a leading provider of processing and storage of umbilical cord stem cells, has obtained a license to PharmaStem’s patent portfolio. This agreement will allow Lifebank to successfully market its services in the United States.
